Effect of angiotensin II receptor blocker, valsartan, on insulin resistance of schizophrenic patients with olanzapine treatment

被引：0
|
作者：
Yamashita, Hakuei
Yoda, Hiroo
Saito, Masashi
Kuwabara, Michiko
Odagaki, Yuji
Kazawa, Tetsushi
Kikuchi, Atsuko
Maruki, Taeko
Toyoshima, Ryoichi
Kawazu, Shoji
机构：
[1] Moro Hosp, Dept Psychiat, Saitama, Japan
[2] Saitama Med Univ, Fac Med, Sch Med, Dept Neuropsychiat, Saitama, Japan
[3] Saitama Med Univ Hosp, Hlth Management Ctr, Saitama, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
O31
引用
收藏
页码：A9 / A10
页数：2
相关论文
共 50 条
  • [41] Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension
    Skurk, T
    Lee, YM
    Nicuta-Rölfs, TO
    Haastert, B
    Wirth, A
    Hauner, H
    DIABETES OBESITY & METABOLISM, 2004, 6 (01): : 56 - 62
  • [42] Effects of candesartan, an angiotensin II receptor blocker, versus diet only on insulin resistance assessed by HOMA
    Kawai, T
    Tabata, M
    Shigihara, T
    Saisho, Y
    Hirose, H
    Shimada, A
    Saruta, T
    DIABETES, 2005, 54 : A527 - A527
  • [43] Angiotensin II Receptor Blocker Ameliorates Stress-Induced Adipose Tissue Inflammation and Insulin Resistance
    Hayashi, Motoharu
    Takeshita, Kyosuke
    Uchida, Yasuhiro
    Yamamoto, Koji
    Kikuchi, Ryosuke
    Nakayama, Takayuki
    Nomura, Emiko
    Cheng, Xian Wu
    Matsushita, Tadashi
    Nakamura, Shigeo
    Murohara, Toyoaki
    PLOS ONE, 2014, 9 (12): : e116163
  • [44] Effect of valsartan, an angiotensin II receptor blocker, on markers of oxidation and glycation in Japanese type 2 diabetic subjects: Blood pressure-independent effect of valsartan
    Saisho, Yoshifumi
    Komiya, Naoko
    Hirose, Hiroshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 (02) : 201 - 203
  • [45] Angiotensin II Receptor Blocker And Neprilysin Inhibitor Sacubitril/valsartan Attenuates Experimental Pulmonary Hypertension
    Clements, Richard T.
    Vang, Alexander
    Kue, Nouaying R.
    Mancini, Thomas
    Morrison, Alan R.
    McCullough, Danielle J.
    Mallem, Krishna
    Choudhary, Gaurav
    CIRCULATION, 2019, 140
  • [46] Effect of the angiotensin II receptor blocker valsartan on cardiac hypertrophy and myocardial histone deacetylase expression in rats with aortic constriction
    Xu, Wei-Ping
    Ya, Tong-Qing
    Jiang, Yi-Bo
    Zhang, Mao-Zhen
    Wang, Yue-Peng
    Yu, Ying
    Li, Jing-Xiang
    Li, Yi-Gang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2225 - 2228
  • [47] Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker
    Pool, J
    Oparil, S
    Hedner, T
    Glazer, R
    Oddou-Stock, P
    Hester, A
    CLINICAL THERAPEUTICS, 1998, 20 (06) : 1106 - 1114
  • [48] The effect of the angiotensin II receptor blocker, valsartan on oxidative stress and inflammatory mediators in obese subjects with type 2 diabetes
    Viswanathan, Prabhakar
    Ghanim, Rusam
    Sia, Chang Ling
    Craudhuri, Ajay
    Mohanty, Priya
    Dandona, Paresh
    DIABETES, 2006, 55 : A154 - A154
  • [49] The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19
    de Ligt, Marlies
    Hesselink, Matthijs K. C.
    Jorgensen, Johanna
    Jocken, Johan W. E.
    Blaak, Ellen E.
    Goossens, Gijs H.
    OBESITY, 2021, 29 (09) : 1423 - 1426
  • [50] Angiotensin II receptor blocker, valsartan, suppresses the development of experimental abdominal aortic aneurysm in rats
    Fujiwara, Y.
    Shiraya, S.
    Yamakawa, S.
    Miyake, T.
    Makino, H.
    Aoki, M.
    Nishimura, M.
    Morishita, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S523 - S523
12345